Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Total Assets Over TimeStrong
Percentile Rank100
3Y CAGR+9.4%
5Y CAGR+55.5%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+9.4%/yr
Annual compound
5Y CAGR
+55.5%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
9.1x
Strong expansion
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$448.66M+2.3%
2024$438.73M+44.4%
2023$303.75M-11.3%
2022$342.39M-6.5%
2021$366.33M+641.9%
2020$49.38M+345.1%
2019$11.09M-